Literature DB >> 2292230

Drugs and receptors. An overview of the current state of knowledge.

T Kenakin1.   

Abstract

This paper reviews the theoretical concepts and methods utilised with isolated tissues to characterise drugs and drug receptors. Specifically the impact, on the in vitro measurement of agonist affinity and relative efficacy, of the idea that receptors bind to transduction proteins in the lipid bilayer of the cell membrane is discussed. The effects of ternary complex formation of agonist-receptor equilibria raise theoretical objections to the measurement of agonist receptor equilibrium dissociation constants. Possible 'promiscuity' of receptors with respect to the G-proteins with which they can interact makes classification of receptors by agonists suspect. The use of Schild analysis for the measurement of antagonist affinity and subsequent classification of receptors is considered in the light of recent data showing that estimates calculated with this method are heterogeneous. Resultant analysis for the detection of allosteric effects is also discussed. Lastly, the impact of molecular biology on the drug and drug receptor classification process is considered, as well as the effects of pathological processes on drug action at the receptor level.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2292230     DOI: 10.2165/00003495-199040050-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  147 in total

Review 1.  Biochemical and immunological studies on the regulation of cardiac and neuronal muscarinic acetylcholine receptor number and function.

Authors:  E M Subers; W C Liles; C W Luetje; N M Nathanson
Journal:  Trends Pharmacol Sci       Date:  1988-02       Impact factor: 14.819

2.  Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin.

Authors:  R A Dixon; B K Kobilka; D J Strader; J L Benovic; H G Dohlman; T Frielle; M A Bolanowski; C D Bennett; E Rands; R E Diehl; R A Mumford; E E Slater; I S Sigal; M G Caron; R J Lefkowitz; C D Strader
Journal:  Nature       Date:  1986 May 1-7       Impact factor: 49.962

3.  Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from the cDNA sequence.

Authors:  T Kubo; A Maeda; K Sugimoto; I Akiba; A Mikami; H Takahashi; T Haga; K Haga; A Ichiyama; K Kangawa
Journal:  FEBS Lett       Date:  1986-12-15       Impact factor: 4.124

4.  What do antagonists tell us about alpha-adrenoceptors?

Authors:  G M Drew
Journal:  Clin Sci (Lond)       Date:  1985       Impact factor: 6.124

5.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

Authors:  M R Bristow; R Ginsburg; V Umans; M Fowler; W Minobe; R Rasmussen; P Zera; R Menlove; P Shah; S Jamieson
Journal:  Circ Res       Date:  1986-09       Impact factor: 17.367

6.  Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells.

Authors:  J H Brown; D Goldstein
Journal:  Mol Pharmacol       Date:  1986-12       Impact factor: 4.436

7.  Receptor-mediated inhibition of adenylate cyclase and stimulation of arachidonic acid release in 3T3 fibroblasts. Selective susceptibility to islet-activating protein, pertussis toxin.

Authors:  T Murayama; M Ui
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

8.  The differential loss of [3H]pirenzepine vs [3H] (-) quinuclidinylbenzilate binding to soluble rat brain muscarinic receptors indicates that pirenzepine binds to an allosteric state of the muscarinic receptor.

Authors:  W R Roeske; J C Venter
Journal:  Biochem Biophys Res Commun       Date:  1984-02-14       Impact factor: 3.575

9.  Receptor glycosylation regulates the affinity of histamine H1 receptors during smooth muscle cell differentiation.

Authors:  M Mitsuhashi; D G Payan
Journal:  Mol Pharmacol       Date:  1989-03       Impact factor: 4.436

10.  Effects of pertussis toxin on cAMP and cGMP responses to carbamylcholine in N1E-115 neuroblastoma cells.

Authors:  P Bruni; D L Burns; E L Hewlett; J Moss
Journal:  Mol Pharmacol       Date:  1985-08       Impact factor: 4.436

View more
  15 in total

1.  Plasmon resonance studies of agonist/antagonist binding to the human delta-opioid receptor: new structural insights into receptor-ligand interactions.

Authors:  Z Salamon; S Cowell; E Varga; H I Yamamura; V J Hruby; G Tollin
Journal:  Biophys J       Date:  2000-11       Impact factor: 4.033

Review 2.  GPCR functional selectivity has therapeutic impact.

Authors:  Richard B Mailman
Journal:  Trends Pharmacol Sci       Date:  2007-07-13       Impact factor: 14.819

3.  Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626.

Authors:  B J Bowery; Z Razzaque; F Emms; S Patel; S Freedman; L Bristow; J Kulagowski; G R Seabrook
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

4.  The effect of the beta(2) adrenoceptor gene Thr164Ile polymorphism on human adipose tissue lipolytic function.

Authors:  J Hoffstedt; A Iliadou; N L Pedersen; M Schalling; P Arner
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

5.  Angiotensin converting enzyme binding sites in human heart and lung: comparison with rat tissues.

Authors:  T Vago; M Bevilacqua; F Conci; G Baldi; E Ongini; E Chebat; A Monopoli; G Norbiato
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

6.  Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.

Authors:  B Bowery; L A Rothwell; G R Seabrook
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

7.  Biphasic dose-response curves to arecoline in rat atria-mediation by a single promiscuous receptor or two receptor subtypes?

Authors:  T P Kenakin; C Boselli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-08       Impact factor: 3.000

8.  L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.

Authors:  R J Hargreaves; A T McKnight; K Scholey; N R Newberry; L J Street; P H Hutson; J E Semark; E A Harley; S Patel; S B Freedman
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

Review 9.  Dopamine receptor signaling and current and future antipsychotic drugs.

Authors:  Kevin N Boyd; Richard B Mailman
Journal:  Handb Exp Pharmacol       Date:  2012

10.  Differences in the effects of NK1-receptor antagonists, (+/-)-CP 96,345 and CP 99,994, on agonist-induced responses in guinea-pig trachea.

Authors:  J Longmore; Z Razzaque; D Shaw; R G Hill
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.